HepaLife signs research agreement with USDA
HepaLife is incorporating the PICM-19 cell line in its developmental stage bioartificial liver. HepaLife’s bioartificial liver, designed to operate outside the patient’s body, is envisioned to mimic important
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.